The following pages link to TNF inhibitor
External toolsShowing 50 items.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Membranous glomerulonephritis (links | edit)
- Adalimumab (links | edit)
- Anakinra (links | edit)
- Penicillamine (links | edit)
- Lenalidomide (links | edit)
- Natalizumab (links | edit)
- Pentoxifylline (links | edit)
- Aminophylline (links | edit)
- SAPHO syndrome (links | edit)
- Cladribine (links | edit)
- Alemtuzumab (links | edit)
- Intermammary cleft (links | edit)
- Microscopic colitis (links | edit)
- Inflammatory arthritis (links | edit)
- Ravinder Maini (links | edit)
- Immune reconstitution inflammatory syndrome (links | edit)
- Experimental autoimmune encephalomyelitis (links | edit)
- Paraxanthine (links | edit)
- Leflunomide (links | edit)
- Jarisch–Herxheimer reaction (links | edit)
- Descending colon (links | edit)
- Failed back syndrome (links | edit)
- Muromonab-CD3 (links | edit)
- Uterine atony (links | edit)
- Efalizumab (links | edit)
- Nomenclature of monoclonal antibodies (links | edit)
- Alefacept (links | edit)
- Gusperimus (links | edit)
- Certolizumab pegol (links | edit)
- Biological therapy for inflammatory bowel disease (links | edit)
- Jan Vilček (links | edit)
- Eculizumab (links | edit)
- Orofacial granulomatosis (links | edit)
- Belatacept (links | edit)
- Biological response modifier (links | edit)
- Inflammatory demyelinating diseases of the central nervous system (links | edit)
- Ustekinumab (links | edit)
- Gavilimomab (links | edit)
- Afelimomab (links | edit)
- Faralimomab (links | edit)
- Aselizumab (links | edit)
- Atorolimumab (links | edit)
- Belimumab (links | edit)
- Bertilimumab (links | edit)
- Cedelizumab (links | edit)
- Lerdelimumab (links | edit)
- Metelimumab (links | edit)
- Zanolimumab (links | edit)
- Zolimomab aritox (links | edit)
- Elsilimomab (links | edit)